News & Updates

LSD-assisted therapy may provide lasting relief from anxiety

People with anxiety disorders appear to obtain lasting benefits from lysergic acid diethylamide (LSD)-assisted therapy, with improved wellbeing, reduced neuroticism, and increased extraversion, as shown in a study.

To Obesity and Beyond: The Effects of GLP-1 RA for Weight Managements on Cardiovascular Health

Add-on atezolizumab of no benefit in HER2-positive breast cancer with brain metastases

Using atezolizumab in addition to pertuzumab plus high-dose trastuzumab does not appear to improve central nervous system (CNS) responses in HER2-positive breast cancer patients with brain metastases, according to the results of a single-arm phase II study.

Obesity linked to heightened risk of sleep-related breathing disorders in kids

Children with obesity face an increased risk of sleep-related breathing disorders, similar to those with Prader-Willi syndrome, as reported in a retrospective study.

Evidence supports semaglutide for obesity-related HFpEF

Semaglutide improves exercise function in patients with obesity-related heart failure with preserved ejection fraction (HFpEF) in a secondary analysis of the prespecified pooled STEP-HFpEF and STEP-HFpEF DM trials presented at HFSA 2024.

Patients with acute anterior uveitis prone to ipsilateral recurrence

Recurrence in the ipsilateral eye is not uncommon in nearly half of patients with acute anterior uveitis (AAU), while one in four may experience recurrence in the contralateral eye, suggests a study.

Vasopressin injection reduces bleeding, surgery time in ovarian endometrioma cystectomy

In women with ovarian endometrioma, those who receive vasopressin injection during laparoscopic cystectomy experience shorter operation time, have reduced blood loss, and fewer coagulation events, as shown in a study presented at RCOG 2024.

Faricimab trumps aflibercept in diabetic macular edema

Treatment with faricimab demonstrates similar visual acuity and greater retinal thickness reduction, with fewer injections, when compared with aflibercept therapy in patients with diabetic macular edema (DME), reports a recent study.